Northern Trust’s Fusion Pharmaceuticals FUSN Stock Holding History
Bought
Maintained
Sold
Northern Trust's FUSN Position: Q2 2024 in Review
Northern Trust sold out of Fusion Pharmaceuticals (FUSN) in Q2 2024, closing a stake of 13,983 shares — an estimated $298K sold.
Northern Trust first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $298K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- Northern Trust reported no remaining Fusion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Northern Trust sold 13,983 Fusion Pharmaceuticals shares in Q2 2024, an estimated $298K.
- Northern Trust first reported a position in Fusion Pharmaceuticals in Q1 2024 and held it in 1 quarter.
- Northern Trust's Fusion Pharmaceuticals position peaked at $298K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q2 2024.
Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.